Literature DB >> 24780527

Tobacco control environment in the United States and individual consumer characteristics in relation to continued smoking: differential responses among menthol smokers?

Michael Lewis1, Yanwen Wang2, Carla J Berg3.   

Abstract

OBJECTIVE: We used a consumer panel augmented with state-specific measures of tobacco control activities to examine the main effects and interactions among consumer behaviors, particularly menthol cigarette smoking, and tobacco control environment on cessation over a six-year period.
METHODS: We used the Nielson Homescan Panel, which tracks consumer purchasing behaviors, and tobacco control information matched to panelist zip code. We focused on 1582 households purchasing ≥20 packs from 2004 to 2009. Our analysis included demographics; purchasing behavior including menthol versus nonmenthol use (≥80% of cigarettes purchased being menthol), quality preferences (average price/pack), purchase recency, and nicotine intake (nicotine levels of cigarettes purchased); and tobacco control metrics (taxation, anti-tobacco advertising, smoke-free policies).
RESULTS: Menthol smoking (Hazard Ratio [HR]=0.79, 95% Confidence Interval [CI] 0.64, 0.99), being African American (HR=0.67, CI 0.46, 0.98), being male (HR=0.46, CI 0.28, 0.74), higher quality premium preferences (HR=0.80, CI 0.77, 0.91), lower recency (HR=1.04, CI 1.02, 1.05), and higher nicotine intake rates (HR=0.99, CI 0.99, 0.99) were related to continued smoking. No significant interactions were found.
CONCLUSION: While there were no interactions between menthol use and effects of tobacco control activities, we did find additional support for the decreased cessation rates among menthol cigarette smokers, particularly in the African American population.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Smoking; Smoking cessation; Tobacco use

Mesh:

Substances:

Year:  2014        PMID: 24780527      PMCID: PMC4101025          DOI: 10.1016/j.ypmed.2014.04.019

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  19 in total

1.  Differences in smoking and quitting experiences by levels of smoking among African Americans.

Authors:  Kolawole S Okuyemi; Jasjit S Ahluwalia; Rachel Banks; Kari Jo Harris; Michael C Mosier; Niaman Nazir; Joshua Powell
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

2.  Comparison of smoking relapse curves among African-American smokers.

Authors:  Won S Choi; Kolawole S Okuyemi; Harsohena Kaur; Jasjit S Ahluwalia
Journal:  Addict Behav       Date:  2004-11       Impact factor: 3.913

3.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

4.  Assessment of the integration of the ecological approach in health promotion programs.

Authors:  L Richard; L Potvin; N Kishchuk; H Prlic; L W Green
Journal:  Am J Health Promot       Date:  1996 Mar-Apr

Review 5.  Translating social ecological theory into guidelines for community health promotion.

Authors:  D Stokols
Journal:  Am J Health Promot       Date:  1996 Mar-Apr

6.  Response to increases in cigarette prices by race/ethnicity, income, and age groups--United States, 1976-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-07-31       Impact factor: 17.586

Review 7.  An ecological perspective on health promotion programs.

Authors:  K R McLeroy; D Bibeau; A Steckler; K Glanz
Journal:  Health Educ Q       Date:  1988

8.  Nicotine metabolism variability and nicotine addiction.

Authors:  K Ahijevych
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

9.  African-American menthol and nonmenthol smokers: differences in smoking and cessation experiences.

Authors:  Kolawole S Okuyemi; Maiko Ebersole-Robinson; Niaman Nazir; Jasjit S Ahluwalia
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

10.  Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.

Authors:  Kari Jo Harris; Kolawole S Okuyemi; Delwyn Catley; Matthew S Mayo; Bin Ge; Jasjit S Ahluwalia
Journal:  Prev Med       Date:  2004-04       Impact factor: 4.018

View more
  7 in total

1.  Use of Mentholated Cigarettes and Likelihood of Smoking Cessation in the United States: A Meta-Analysis.

Authors:  Philip H Smith; Biruktawit Assefa; Simranpreet Kainth; Kaliris Y Salas-Ramirez; Sherry A McKee; Gary A Giovino
Journal:  Nicotine Tob Res       Date:  2020-03-16       Impact factor: 4.244

2.  Menthol smokers in large-scale nicotine replacement therapy program.

Authors:  Sayone Thihalolipavan; Molly Jung; John Jasek; Shadi Chamany
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

3.  Effects of Menthol Flavor Cigarettes or Total Urinary Menthol on Biomarkers of Nicotine and Carcinogenic Exposure and Behavioral Measures.

Authors:  Karen Ahijevych; Laura A Szalacha; Alai Tan
Journal:  Nicotine Tob Res       Date:  2019-08-19       Impact factor: 4.244

Review 4.  National Surveys and Tobacco Use Among African Americans: A Review of Critical Factors.

Authors:  Italia V Rolle; Derrick D Beasley; Sara M Kennedy; Valerie J Rock; Linda Neff
Journal:  Nicotine Tob Res       Date:  2016-04       Impact factor: 4.244

5.  Examining e-cigarette purchases and cessation in a consumer panel of smokers.

Authors:  Zachary Cahn; Regine Haardörfer; Michael Lewis; Yanwen Wang; Carla J Berg
Journal:  J Smok Cessat       Date:  2018-04-05

Review 6.  Menthol cigarettes and the public health standard: a systematic review.

Authors:  Andrea C Villanti; Lauren K Collins; Raymond S Niaura; Stacey Y Gagosian; David B Abrams
Journal:  BMC Public Health       Date:  2017-12-29       Impact factor: 3.295

7.  An exploratory analysis of cigarette price premium, market share and consumer loyalty in relation to continued consumption versus cessation in a national US panel.

Authors:  Michael Lewis; Yanwen Wang; Zachary Cahn; Carla J Berg
Journal:  BMJ Open       Date:  2015-11-03       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.